Vizionfocus Inc. (TPE:4771)
Taiwan · Delayed Price · Currency is TWD 178.00
-0.50 (-0.28%)
Oct 23, 2025, 2:36 PM CST
Vizionfocus Revenue
Vizionfocus had revenue of 872.36M TWD in the quarter ending June 30, 2025, with 19.54% growth. This brings the company's revenue in the last twelve months to 3.19B, up 5.96% year-over-year. In the year 2024, Vizionfocus had annual revenue of 3.00B with 16.71% growth.
Revenue (ttm)
3.19B
Revenue Growth
+5.96%
P/S Ratio
3.26
Revenue / Employee
n/a
Employees
438
Market Cap
10.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.00B | 429.81M | 16.71% |
| Dec 31, 2023 | 2.57B | 737.88M | 40.23% |
| Dec 31, 2022 | 1.83B | 414.63M | 29.21% |
| Dec 31, 2021 | 1.42B | 564.54M | 66.02% |
| Dec 31, 2020 | 855.15M | 270.28M | 46.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.67B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |